世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

NA心臓弁の修復と置換市場-2035年までの産業動向と予測


NA Heart Valve Repair and Replacement Market- Industry Trends and Forecast to 2035

北米の心臓弁修理・交換市場は、2024年の54億8,539万ドルから2031年には115億8,565万ドルに達し、2024年から2031年の予測期間において11.3%の大幅な年平均成長率で成長すると予測されている。 市場細分化: ... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Data Bridge Market Research
データブリッジマーケットリサーチ
2024年1月1日 US$3,500
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
175 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

北米の心臓弁修理・交換市場は、2024年の54億8,539万ドルから2031年には115億8,565万ドルに達し、2024年から2031年の予測期間において11.3%の大幅な年平均成長率で成長すると予測されている。

市場細分化:
北米の心臓弁修復置換市場:製品別(外科的心臓弁置換術、外科的心臓弁修復術、Tavi / Tavr弁、グラフト、パッチ、投薬、その他)、手技別(外科的手技、非外科的手技)、適応症(弁膜症性狭窄、弁膜症性不全、僧帽弁逸脱、その他)、エンドユーザー(病院、専門センター、心臓カテーテル検査室、外来手術センター、その他)、流通チャネル(直接入札、小売販売、その他)、国(U.S.,産業動向と2031年までの予測

北米の心臓弁修復置換市場ダイナミクスの概要

促進要因
- 心臓弁膜症の増加
抑制要因

- 心血管疾患治療に伴う高コスト

機会

- 低侵襲技術に対する需要の高まり


市場プレーヤー

北米の心臓弁修復・置換市場で事業を展開する主なプレーヤーは以下の通り:
- MVRx, Inc.
- MeKoレーザー材料加工
- コメッドB.V.
- カルディアメッド
- ゼルティス
- フォルダックス社
- イエナバルブテクノロジー社
- コリブリ心臓弁
- HLT社
- ネオコード社
- メリル・ライフサイエンス社
- マイクロインターベンショナルデバイス社
- バイオトロニック
- メドトロニック
- アボット
- ネオバス
- エドワーズライフサイエンス社







ページTOPに戻る


目次

TABLE OF CONTENTS
1 INTRODUCTION 48
1.1 OBJECTIVES OF THE STUDY 48
1.2 MARKET DEFINITION 48
1.3 OVERVIEW OF NORTH AMERICA HEART VALVE REPAIR AND REPLACEMENT MARKET 48
1.4 LIMITATIONS 50
1.5 MARKETS COVERED 50
2 MARKET SEGMENTATION 53
2.1 MARKETS COVERED 53
2.2 GEOGRAPHICAL SCOPE 54
2.3 YEARS CONSIDERED FOR THE STUDY 55
2.4 CURRENCY AND PRICING 55
2.5 DBMR TRIPOD DATA VALIDATION MODEL 56
2.6 MULTIVARIATE MODELLING 59
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 60
2.8 DBMR MARKET POSITION GRID 61
2.9 MARKET END USER COVERAGE GRID 62
2.10 VENDOR SHARE ANALYSIS 63
2.11 SECONDARY SOURCES 64
2.12 ASSUMPTIONS 64
3 EXECUTIVE SUMMARY 65
4 PREMIUM INSIGHTS 67
5 REIMBURSEMENT SCENARIO FOR HEART VALVE REPAIR AND REPLACEMENT 68
6 NORTH AMERICA HEART VALVE REPAIR AND REPLACEMENT MARKET: REGULATIONS 73
6.1 REGULATIONS IN THE U.S. 73
6.2 REGULATIONS IN EUROPE 74
6.3 REGULATIONS IN CHINA 74
6.4 REGULATIONS IN INDIA 75
7 MARKET OVERVIEW 76
7.1 DRIVERS 78
7.1.1 RISE IN INCIDENCE OF VALVULAR HEART DEFECTS 78
7.1.2 INCREASE IN THE GERIATRIC POPULATION 78
7.1.3 FAVORABLE HEALTHCARE REIMBURSEMENT POLICIES 79
7.1.4 INCREASING TECHNOLOGICAL ADVANCEMENTS IN HEALTHCARE SECTOR 80
7.2 RESTRAINTS 81
7.2.1 HIGH COST ASSOCIATED WITH CARDIOVASCULAR DISEASE TREATMENT 81
7.2.2 COMPLICATIONS ASSOCIATED WITH HEART VALVE REPLACEMENT 81
7.3 OPPORTUNITIES 83
7.3.1 RISE IN THE OBESE POPULATION NORTH AMERICALY 83
7.3.2 RISE IN DEMAND FOR MINIMALLY INVASIVE TECHNOLOGY 84
7.3.3 RISING GOVERNMENT EXPENDITURE ON THE HEALTHCARE SECTOR 84
7.4 CHALLENGES 85
7.4.1 STRINGENT RULES AND REGULATIONS FOR GOVERNMENT APPROVAL IN THE HEALTHCARE SECTOR 85
8 NORTH AMERICA HEART VALVE REPAIR AND REPLACEMENT MARKET, BY PRODUCT 86
8.1 OVERVIEW 87
8.2 SURGICAL HEART VALVE REPLACEMENT 88
8.2.1 SURGICAL HEART VALVE REPLACEMENT, BY PRODUCT 89
8.2.1.1 AORTIC, BY PRODUCT 89
8.2.1.2 TISSUE VALVE, BY PRODUCT 89
8.2.1.2.1 TISSUE VALVE, BY TYPE 90
8.2.1.3 AORTIC, BY TYPE 90
8.2.1.4 MITRAL, BY PRODUCT 90
8.2.1.4.1 TISSUE VALVE, BY TYPE 91
8.3 SURGICAL HEART VALVE REPAIR 91
8.3.1 SURGICAL HEART VALVE REPAIR, BY PRODUCT 91
8.3.1.1 MITRAL, BY PRODUCT 92
8.3.1.2 RINGS, BY TYPE 92
8.4 TAVI / TAVR VALVE 92
8.5 GRAFTS 93
8.6 PATCHES 93
8.7 MEDICATION 94
8.8 OTHERS 94
9 NORTH AMERICA HEART VALVE REPAIR AND REPLACEMENT MARKET, BY PROCEDURE 95
9.1 OVERVIEW 96
9.2 SURGICAL PROCEDURE 97
9.2.1 SURGICAL PROCEDURE, BY PROCEDURE 97
9.2.1.1 HEART VALVE REPLACEMENT, BY PROCEDURE 97
9.2.1.2 HEART VALVE REPAIR, BY PROCEDURE 98
9.3 NON-SURGICAL PROCEDURE 99
10 NORTH AMERICA HEART VALVE REPAIR AND REPLACEMENT MARKET, BY INDICATION 100
10.1 OVERVIEW 101
10.2 VALVULAR STENOSIS 102
10.2.1 VALVULAR STENOSIS, BY TYPE 102
10.3 VALVULAR INSUFFICIENCY 103
10.3.1 VALVULAR INSUFFICIENCY, BY TYPE 103
10.4 MITRAL VALVE PROLAPSE 104
10.5 OTHERS 104
11 NORTH AMERICA HEART VALVE REPAIR AND REPLACEMENT MARKET, BY END USER 105
11.1 OVERVIEW 106
11.2 HOSPITAL 107
11.3 AMBULATORY SURGICAL CENTERS 108
11.4 SPECIALTY CENTERS 108
11.5 CARDIAC CATHETERIZATION LAB 109
11.6 OTHERS 109
12 NORTH AMERICA HEART VALVE REPAIR AND REPLACEMENT MARKET, BY DISTRIBUTION CHANNEL 110
12.1 OVERVIEW 111
12.2 DIRECT TENDER 112
12.3 RETAIL SALES 113
12.4 OTHERS 113
13 NORTH AMERICA HEART VALVE REPAIR AND REPLACEMENT MARKET, BY REGION 114
13.1 NORTH AMERICA 115
13.1.1 U.S. 123
13.1.2 CANADA 129
13.1.3 MEXICO 135
14 NORTH AMERICA HEART VALVE REPAIR AND REPLACEMENT MARKET: COMPANY LANDSCAPE 140
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 140

15 SWOT ANALYSIS 141
16 COMPANY PROFILES 142
16.1 ABBOTT 142
16.1.1 COMPANY SNAPSHOT 142
16.1.2 REVENUE ANALYSIS 142
16.1.3 COMPANY SHARE ANALYSIS 143
16.1.4 PRODUCT PORTFOLIO 143
16.1.5 RECENT DEVELOPMENTS 144
16.2 EDWARDS LIFESCIENCES CORPORATION 145
16.2.1 COMPANY SNAPSHOT 145
16.2.2 REVENUE ANALYSIS 145
16.2.3 COMPANY SHARE ANALYSIS 146
16.2.4 PRODUCT PORTFOLIO 146
16.2.5 RECENT DEVELOPMENTS 147
16.3 MEDTRONIC 148
16.3.1 COMPANY SNAPSHOT 148
16.3.2 REVENUE ANALYSIS 148
16.3.3 COMPANY SHARE ANALYSIS 149
16.3.4 PRODUCT PORTFOLIO 149
16.3.5 RECENT DEVELOPMENTS 150
16.4 BIOTRONIK 151
16.4.1 COMPANY SNAPSHOT 151
16.4.2 PRODUCT PORTFOLIO 151
16.4.3 COMPANY SHARE ANALYSIS 151
16.4.4 RECENT DEVELOPMENT 151
16.5 MERIL LIFE SCIENCES PVT. LTD. 152
16.5.1 COMPANY SNAPSHOT 152
16.5.2 COMPANY SHARE ANALYSIS 152
16.5.3 PRODUCT PORTFOLIO 153
16.5.4 RECENT DEVELOPMENT 153
16.6 CARDIAMED 154
16.6.1 COMPANY SNAPSHOT 154
16.6.2 PRODUCT PORTFOLIO 154
16.6.3 RECENT DEVELOPMENT 154
16.7 COMED B.V. 155
16.7.1 COMPANY SNAPSHOT 155
16.7.2 PRODUCT PORTFOLIO 155
16.7.3 RECENT DEVELOPMENT 155

16.8 COLIBRI HEART VALVE 156
16.8.1 COMPANY SNAPSHOT 156
16.8.2 PRODUCT PORTFOLIO 156
16.8.3 RECENT DEVELOPMENT 156
16.9 FOLDAX, INC. 157
16.9.1 COMPANY SNAPSHOT 157
16.9.2 PRODUCT PORTFOLIO 157
16.9.3 RECENT DEVELOPMENTS 157
16.10 HLT, INC. 159
16.10.1 COMPANY SNAPSHOT 159
16.10.2 PRODUCT PORTFOLIO 159
16.10.3 RECENT DEVELOPMENT 159
16.11 JENAVALVE TECHNOLOGY, INC. 160
16.11.1 COMPANY SNAPSHOT 160
16.11.2 PRODUCT PORTFOLIO 160
16.11.3 RECENT DEVELOPMENT 160
16.12 MEKO LASER MATERIAL PROCESSING 161
16.12.1 COMPANY SNAPSHOT 161
16.12.2 PRODUCT PORTFOLIO 161
16.12.3 RECENT DEVELOPMENTS 161
16.13 MICRO INTERVENTIONAL DEVICES, INC. 162
16.13.1 COMPANY SNAPSHOT 162
16.13.2 PRODUCT PORTFOLIO 162
16.13.3 RECENT DEVELOPMENT 162
16.14 MVRX, INC. 163
16.14.1 COMPANY SNAPSHOT 163
16.14.2 PRODUCT PORTFOLIO 163
16.14.3 RECENT DEVELOPMENTS 163
16.15 NEOCHORD, INC. 164
16.15.1 COMPANY SNAPSHOT 164
16.15.2 PRODUCT PORTFOLIO 164
16.15.3 RECENT DEVELOPMENTS 165
16.16 NEOVASC, INC. 166
16.16.1 COMPANY SNAPSHOT 166
16.16.2 REVENUE ANALYSIS 166
16.16.3 PRODUCT PORTFOLIO 167
16.16.4 RECENT DEVELOPMENTS 167 
16.17 XELTIS 168
16.17.1 COMPANY SNAPSHOT 168
16.17.2 PRODUCT PORTFOLIO 168
16.17.3 RECENT DEVELOPMENTS 168
17 QUESTIONNAIRE 170
18 RELATED REPORTS 175

 

ページTOPに戻る


 

Summary

The North America heart valve repair and replacement market is expected to reach USD 11,585.65 million by 2031 from 5,485.39 million in 2024, growing with a substantial CAGR of 11.3% in the forecast period of 2024 to 2031.

Market Segmentation:
North America Heart Valve Repair And Replacement Market, By Product (Surgical Heart Valve Replacement, Surgical Heart Valve Repair, Tavi / Tavr Valves, Grafts, Patches, Medication, and Others), Procedure (Surgical Procedure and Non-Surgical Procedure), Indication (Valvular Stenosis, Valvular Insufficiency, Mitral Valve Prolapse, and Others), End User (Hospital, Specialty Centers, Cardiac Catheterization Lab, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2031

Overview of North America Heart Valve Repair And Replacement Market Dynamics

Driver
• Rise in incidence of valvular heart defects
Restraint

• High cost associated with cardiovascular disease treatment

Opportunity

• Rise in demand for minimally invasive technology


Market Players

Some of the key players operating in the North America heart valve repair and replacement market are:
• MVRx, Inc.
• MeKo Laser Material Processing
• Comed B.V.
• CardiaMed
• Xeltis
• Foldax, Inc.
• JenaValve Technology, Inc.
• Colibri Heart Valve
• HLT, Inc.
• NeoChord, Inc.
• Meril Life Sciences Pvt. Ltd.
• Micro Interventional Devices, Inc.
• Biotronik
• Medtronic
• Abbott
• Neovasc Inc.
• Edwards Lifesciences Corporation







ページTOPに戻る


Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 48
1.1 OBJECTIVES OF THE STUDY 48
1.2 MARKET DEFINITION 48
1.3 OVERVIEW OF NORTH AMERICA HEART VALVE REPAIR AND REPLACEMENT MARKET 48
1.4 LIMITATIONS 50
1.5 MARKETS COVERED 50
2 MARKET SEGMENTATION 53
2.1 MARKETS COVERED 53
2.2 GEOGRAPHICAL SCOPE 54
2.3 YEARS CONSIDERED FOR THE STUDY 55
2.4 CURRENCY AND PRICING 55
2.5 DBMR TRIPOD DATA VALIDATION MODEL 56
2.6 MULTIVARIATE MODELLING 59
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 60
2.8 DBMR MARKET POSITION GRID 61
2.9 MARKET END USER COVERAGE GRID 62
2.10 VENDOR SHARE ANALYSIS 63
2.11 SECONDARY SOURCES 64
2.12 ASSUMPTIONS 64
3 EXECUTIVE SUMMARY 65
4 PREMIUM INSIGHTS 67
5 REIMBURSEMENT SCENARIO FOR HEART VALVE REPAIR AND REPLACEMENT 68
6 NORTH AMERICA HEART VALVE REPAIR AND REPLACEMENT MARKET: REGULATIONS 73
6.1 REGULATIONS IN THE U.S. 73
6.2 REGULATIONS IN EUROPE 74
6.3 REGULATIONS IN CHINA 74
6.4 REGULATIONS IN INDIA 75
7 MARKET OVERVIEW 76
7.1 DRIVERS 78
7.1.1 RISE IN INCIDENCE OF VALVULAR HEART DEFECTS 78
7.1.2 INCREASE IN THE GERIATRIC POPULATION 78
7.1.3 FAVORABLE HEALTHCARE REIMBURSEMENT POLICIES 79
7.1.4 INCREASING TECHNOLOGICAL ADVANCEMENTS IN HEALTHCARE SECTOR 80
7.2 RESTRAINTS 81
7.2.1 HIGH COST ASSOCIATED WITH CARDIOVASCULAR DISEASE TREATMENT 81
7.2.2 COMPLICATIONS ASSOCIATED WITH HEART VALVE REPLACEMENT 81
7.3 OPPORTUNITIES 83
7.3.1 RISE IN THE OBESE POPULATION NORTH AMERICALY 83
7.3.2 RISE IN DEMAND FOR MINIMALLY INVASIVE TECHNOLOGY 84
7.3.3 RISING GOVERNMENT EXPENDITURE ON THE HEALTHCARE SECTOR 84
7.4 CHALLENGES 85
7.4.1 STRINGENT RULES AND REGULATIONS FOR GOVERNMENT APPROVAL IN THE HEALTHCARE SECTOR 85
8 NORTH AMERICA HEART VALVE REPAIR AND REPLACEMENT MARKET, BY PRODUCT 86
8.1 OVERVIEW 87
8.2 SURGICAL HEART VALVE REPLACEMENT 88
8.2.1 SURGICAL HEART VALVE REPLACEMENT, BY PRODUCT 89
8.2.1.1 AORTIC, BY PRODUCT 89
8.2.1.2 TISSUE VALVE, BY PRODUCT 89
8.2.1.2.1 TISSUE VALVE, BY TYPE 90
8.2.1.3 AORTIC, BY TYPE 90
8.2.1.4 MITRAL, BY PRODUCT 90
8.2.1.4.1 TISSUE VALVE, BY TYPE 91
8.3 SURGICAL HEART VALVE REPAIR 91
8.3.1 SURGICAL HEART VALVE REPAIR, BY PRODUCT 91
8.3.1.1 MITRAL, BY PRODUCT 92
8.3.1.2 RINGS, BY TYPE 92
8.4 TAVI / TAVR VALVE 92
8.5 GRAFTS 93
8.6 PATCHES 93
8.7 MEDICATION 94
8.8 OTHERS 94
9 NORTH AMERICA HEART VALVE REPAIR AND REPLACEMENT MARKET, BY PROCEDURE 95
9.1 OVERVIEW 96
9.2 SURGICAL PROCEDURE 97
9.2.1 SURGICAL PROCEDURE, BY PROCEDURE 97
9.2.1.1 HEART VALVE REPLACEMENT, BY PROCEDURE 97
9.2.1.2 HEART VALVE REPAIR, BY PROCEDURE 98
9.3 NON-SURGICAL PROCEDURE 99
10 NORTH AMERICA HEART VALVE REPAIR AND REPLACEMENT MARKET, BY INDICATION 100
10.1 OVERVIEW 101
10.2 VALVULAR STENOSIS 102
10.2.1 VALVULAR STENOSIS, BY TYPE 102
10.3 VALVULAR INSUFFICIENCY 103
10.3.1 VALVULAR INSUFFICIENCY, BY TYPE 103
10.4 MITRAL VALVE PROLAPSE 104
10.5 OTHERS 104
11 NORTH AMERICA HEART VALVE REPAIR AND REPLACEMENT MARKET, BY END USER 105
11.1 OVERVIEW 106
11.2 HOSPITAL 107
11.3 AMBULATORY SURGICAL CENTERS 108
11.4 SPECIALTY CENTERS 108
11.5 CARDIAC CATHETERIZATION LAB 109
11.6 OTHERS 109
12 NORTH AMERICA HEART VALVE REPAIR AND REPLACEMENT MARKET, BY DISTRIBUTION CHANNEL 110
12.1 OVERVIEW 111
12.2 DIRECT TENDER 112
12.3 RETAIL SALES 113
12.4 OTHERS 113
13 NORTH AMERICA HEART VALVE REPAIR AND REPLACEMENT MARKET, BY REGION 114
13.1 NORTH AMERICA 115
13.1.1 U.S. 123
13.1.2 CANADA 129
13.1.3 MEXICO 135
14 NORTH AMERICA HEART VALVE REPAIR AND REPLACEMENT MARKET: COMPANY LANDSCAPE 140
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 140

15 SWOT ANALYSIS 141
16 COMPANY PROFILES 142
16.1 ABBOTT 142
16.1.1 COMPANY SNAPSHOT 142
16.1.2 REVENUE ANALYSIS 142
16.1.3 COMPANY SHARE ANALYSIS 143
16.1.4 PRODUCT PORTFOLIO 143
16.1.5 RECENT DEVELOPMENTS 144
16.2 EDWARDS LIFESCIENCES CORPORATION 145
16.2.1 COMPANY SNAPSHOT 145
16.2.2 REVENUE ANALYSIS 145
16.2.3 COMPANY SHARE ANALYSIS 146
16.2.4 PRODUCT PORTFOLIO 146
16.2.5 RECENT DEVELOPMENTS 147
16.3 MEDTRONIC 148
16.3.1 COMPANY SNAPSHOT 148
16.3.2 REVENUE ANALYSIS 148
16.3.3 COMPANY SHARE ANALYSIS 149
16.3.4 PRODUCT PORTFOLIO 149
16.3.5 RECENT DEVELOPMENTS 150
16.4 BIOTRONIK 151
16.4.1 COMPANY SNAPSHOT 151
16.4.2 PRODUCT PORTFOLIO 151
16.4.3 COMPANY SHARE ANALYSIS 151
16.4.4 RECENT DEVELOPMENT 151
16.5 MERIL LIFE SCIENCES PVT. LTD. 152
16.5.1 COMPANY SNAPSHOT 152
16.5.2 COMPANY SHARE ANALYSIS 152
16.5.3 PRODUCT PORTFOLIO 153
16.5.4 RECENT DEVELOPMENT 153
16.6 CARDIAMED 154
16.6.1 COMPANY SNAPSHOT 154
16.6.2 PRODUCT PORTFOLIO 154
16.6.3 RECENT DEVELOPMENT 154
16.7 COMED B.V. 155
16.7.1 COMPANY SNAPSHOT 155
16.7.2 PRODUCT PORTFOLIO 155
16.7.3 RECENT DEVELOPMENT 155

16.8 COLIBRI HEART VALVE 156
16.8.1 COMPANY SNAPSHOT 156
16.8.2 PRODUCT PORTFOLIO 156
16.8.3 RECENT DEVELOPMENT 156
16.9 FOLDAX, INC. 157
16.9.1 COMPANY SNAPSHOT 157
16.9.2 PRODUCT PORTFOLIO 157
16.9.3 RECENT DEVELOPMENTS 157
16.10 HLT, INC. 159
16.10.1 COMPANY SNAPSHOT 159
16.10.2 PRODUCT PORTFOLIO 159
16.10.3 RECENT DEVELOPMENT 159
16.11 JENAVALVE TECHNOLOGY, INC. 160
16.11.1 COMPANY SNAPSHOT 160
16.11.2 PRODUCT PORTFOLIO 160
16.11.3 RECENT DEVELOPMENT 160
16.12 MEKO LASER MATERIAL PROCESSING 161
16.12.1 COMPANY SNAPSHOT 161
16.12.2 PRODUCT PORTFOLIO 161
16.12.3 RECENT DEVELOPMENTS 161
16.13 MICRO INTERVENTIONAL DEVICES, INC. 162
16.13.1 COMPANY SNAPSHOT 162
16.13.2 PRODUCT PORTFOLIO 162
16.13.3 RECENT DEVELOPMENT 162
16.14 MVRX, INC. 163
16.14.1 COMPANY SNAPSHOT 163
16.14.2 PRODUCT PORTFOLIO 163
16.14.3 RECENT DEVELOPMENTS 163
16.15 NEOCHORD, INC. 164
16.15.1 COMPANY SNAPSHOT 164
16.15.2 PRODUCT PORTFOLIO 164
16.15.3 RECENT DEVELOPMENTS 165
16.16 NEOVASC, INC. 166
16.16.1 COMPANY SNAPSHOT 166
16.16.2 REVENUE ANALYSIS 166
16.16.3 PRODUCT PORTFOLIO 167
16.16.4 RECENT DEVELOPMENTS 167 
16.17 XELTIS 168
16.17.1 COMPANY SNAPSHOT 168
16.17.2 PRODUCT PORTFOLIO 168
16.17.3 RECENT DEVELOPMENTS 168
17 QUESTIONNAIRE 170
18 RELATED REPORTS 175

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(その他)の最新刊レポート

本レポートと同じKEY WORD(repair)の最新刊レポート


よくあるご質問


Data Bridge Market Research社はどのような調査会社ですか?


データブリッジマーケットリサーチ(Data Bridge Market Research)は500名以上の多様な分野のアナリストが所属するインドの調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/05 10:26

162.17 円

175.82 円

209.73 円

ページTOPに戻る